|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-6-7
|
|
pubmed:abstractText |
C-myc activation is a potent oncogenic event in hepatocarcinogenesis. The aim of this study was to test the preventive effect of interferon-alpha (IFN-alpha) on the development of dysplasia and subsequent hepatocellular carcinoma (HCC) in transgenic (Tg) mice overexpressing c-myc in the liver.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
562-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11394656-Animals,
pubmed-meshheading:11394656-Apoptosis,
pubmed-meshheading:11394656-Carcinoma, Hepatocellular,
pubmed-meshheading:11394656-Cell Division,
pubmed-meshheading:11394656-Female,
pubmed-meshheading:11394656-Hepatitis B,
pubmed-meshheading:11394656-Hepatitis B Virus, Woodchuck,
pubmed-meshheading:11394656-Hepatocytes,
pubmed-meshheading:11394656-Humans,
pubmed-meshheading:11394656-Interferon-alpha,
pubmed-meshheading:11394656-Liver,
pubmed-meshheading:11394656-Liver Neoplasms,
pubmed-meshheading:11394656-Mice,
pubmed-meshheading:11394656-Mice, Transgenic,
pubmed-meshheading:11394656-Precancerous Conditions,
pubmed-meshheading:11394656-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:11394656-Recombinant Proteins
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Preliminary results of interferon-alpha therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic mice.
|
|
pubmed:affiliation |
INSERM Unit 271, Lyon, France.
|
|
pubmed:publicationType |
Journal Article
|
